Nemdatine (Memantine Hydrochloride)

Memantine acts as a non‑competitive antagonist of the NMDA receptor, blocking the excessive calcium influx that occurs when glutamate overstimulates the receptor. This moderates excitotoxic neuronal damage, which is thought to contribute to the progression of Alzheimer’s disease.

The specific dosage of Nemdatine is determined by the prescribing clinician based on the patient’s condition, renal function, and tolerability. Physicians typically start with a low dose and may titrate upward, but exact amounts should only be set by a qualified health professional.

The pregnancy category for memantine hydrochloride is unknown, and there is limited data on its use while breastfeeding. Health care providers should weigh potential benefits against possible risks before prescribing it to pregnant or nursing women.

To place an order, submit an enquiry on the Nemdatine product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

The primary alternative for Alzheimer’s disease is the acetylcholinesterase inhibitor class (e.g., donepezil). While acetylcholinesterase inhibitors increase acetylcholine levels, memantine targets glutamatergic excitotoxicity via NMDA receptor blockade. Both classes may be used together for complementary effects, but they act through different mechanisms.

Nemdatine tablets should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use.

Nemdatine is taken orally, usually with water. The tablet should be swallowed whole and can be taken with or without food, as directed by the prescribing physician.

Serious adverse events include seizures, severe allergic reactions such as Stevens‑Johnson syndrome, hepatic injury, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience any signs of these conditions.

Nemdatine is contraindicated in patients with known hypersensitivity to memantine hydrochloride or any excipients in the tablet. Caution is also advised for individuals with severe renal impairment, uncontrolled seizures, or those taking other NMDA antagonists.